Discussion
Montara Therapeutics received a $1 million grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to develop a Parkinson’s disease treatment designed to work primarily in the brain and minimize effects on the rest of the body. The new drug will target the mTOR biological pathway.
